Shock, Septic: all 890 studies

Page 7 of 9. Open to participants first (210), then studies with results posted, then the rest; newest registration first within each.

• Ketamine Versus Fentanyl for Induction of Anesthesia in Septic ShockCompletedNCT03251170Phase 4
• Efficacy of HFNC Versus NIV for Prevent Reintubation in Sepsis PatientsCompletedNCT03246893Not applicable
• Esmolol to Control Adrenergic Storm in Septic Shock- ROLL-IN 2Status unknownNCT03208257Phase 2
• REmote Ischemic COnditioning in Septic ShockCompletedNCT03201575Not applicable
• Reversibility of Diastolic Disfunction in Septic ShockStatus unknownNCT03198611
• Neuromuscular Electrical Stimulation and Septic ShockSuspendedNCT03193164Not applicable
• Expression of Protein Tyrosine Phosphatase 1B (PTP1B) and Body Composition Modification in Patients With Septic ShockCompletedNCT03189355Not applicable
• Safety and Efficacy of Heparin Dosing Score Protocol for Polymyxin-B HemoperfusionStatus unknownNCT03177330
• Effect of Dexmedetomidine on Perfusion Index and Microcirculation in Severe Sepsis and Septic Shock PatientsStatus unknownNCT03151668Phase 3
• High Versus Low Target Mean Arterial Pressure in Septic Shock in Critically Ill CirrhoticsCompletedNCT03145168Not applicable
• Restrictive Intravenous Fluids Trial in SepsisCompletedNCT03137446Not applicable
• Candida Host Defense Response After Septic Shock in the Critically IllCompletedNCT03136081
• Thiamine Supplementation in Patients With Septic ShockWithdrawnNCT03122678Phase 1
• Evaluating in Cirrhotics With Refractory Vasoplegia the Effect of Methylene BlueCompletedNCT03120637Phase 4
• Proadrenomedullin and Copeptin in Patients With Septic ShockCompletedNCT03104933
• Ketamine Versus Low Dose Thiopental for Induction of Anesthesia in Septic ShockCompletedNCT03104140Phase 3
• Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock (SHOCK) TrialCompletedNCT03092245Phase 2
• Effects of Nursing Staff on Empiric Antibiotic in Septic ShockCompletedNCT03085459
• SQUEEZE Trial: A Trial to Determine Whether Septic Shock Reversal is Quicker in Pediatric Patients Randomized to an Early Goal Directed Fluid Sparing Strategy vs. Usual CareCompletedNCT03080038Not applicable
• Early Goal Directed Therapy Using a Physiological Holistic View. The ANDROMEDA-SHOCK StudyCompletedNCT03078712Not applicable
• Paramedic Initiated Treatment of Sepsis Targeting Out-of-hospital Patients (PITSTOP)CompletedNCT03068741Phase 4
• Plasmaexchange in Early Septic ShockStatus unknownNCT03065751Not applicable
• Neuroimaging and Neuromonitoring in Critically Ill Children With SepsisCompletedNCT03055455
• What Should be the Next Vasopressor for Severe Septic Shock? Methylene Blue or TerlipressinStatus unknownNCT03038503Phase 3
• Propafenone Versus Amiodarone in Septic ShockCompletedNCT03029169Phase 4
• Vasopressin Plasma Concentrations in Patients Receiving Exogenous Vasopressin Infusion for Septic ShockCompletedNCT03014063
• Anticholium® Per SeCompletedNCT03013322Not applicable
• Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA StudyStatus unknownNCT03000049
• Midodrine in the Recovery Phase of Septic ShockWithdrawnNCT02990546Phase 3
• Monitoring Devices in Prediction of Fluid Responsiveness in Severe Sepsis and Septic ShockStatus unknownNCT02972827Not applicable
• Effects of Levosimendan on Cellular Metabolic Alterations in Patients With Septic ShockStatus unknownNCT02963454Not applicable
• Effects of Continuous Haemofiltration vs Intermittent Haemodialysis on Microcirculatory Parameters in Septic ShockStatus unknownNCT02962700Not applicable
• Early Versus Late Sustained Low Efficiency Dialysis in Critically Ill Cirrhotics With Septic Shock and Acute Kidney InjuryStatus unknownNCT02937961Not applicable
• The Role of Dysfunctional HDL in SepsisCompletedNCT02934997
• Prognostic Assessment of Diastolic and Systolic Left Ventricular Function in Septic ShockCompletedNCT02918214
• Place of Echocardiography in IV Fluid Therapy in Patients With Septic Shock and Left Ventricular Systolic DysfunctionCompletedNCT02899897
• Effectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in ChildrenWithdrawnNCT02899702Phase 4
• Application of Stimulated Immune Response Change to Predict Outcome of Patient With Severe SepsisStatus unknownNCT02887274
• Early Metabolic Support as a Potential Solution to Multi-Organ Dysfunction Syndrome (MODS) During Severe SepsisWithdrawnNCT02885688Phase 2
• Modulation of Vasoreactivity in Septic Shock: Impact of Recombinant Protein CCompletedNCT02885168Phase 4
• Treatment of Severe Infections With Mesenchymal Stem CellsStatus unknownNCT02883803Not applicable
• Effects of Chronic Antihypertensive Therapy on Clinical Outcomes in Septic ShockCompletedNCT02876341
• Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock Trial. VIPER-Sepsis (EudraCT no. 2016-000707-81)TerminatedNCT02875236Phase 4
• Application of Biomarkers Change to Predict Outcome of Patient With Severe SepsisStatus unknownNCT02871895
• Study on the Frequency of de Novo Atrial Fibrillation in Septic Shock in Medical Intensive CareCompletedNCT02856191Not applicable
• Pediatric Immune Response to Infectious ShockCompletedNCT02848144Not applicable
• Pilot Study: Echocardiographic and Hemodynamic Effects of Esmolol in Septic Shock PatientsStatus unknownNCT02842983Phase 2/3
• Balanced Crystalloid vs. Saline in Children With Septic ShockCompletedNCT02835157Not applicable
• Open-label Evaluation of Polymyxin B Hemoperfusion for Septic ShockTemporarily not availableNCT02825329
• PK/PD of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic ShockCompletedNCT02820987Phase 3
• Quality Improvement in Infection COntrol and Sepsis Management in MOdel RegionsCompletedNCT02820675Not applicable
• Pharmacokinetic Study on Echinocandins for Patients With Septic Shock Following Secondary Peritonitis (EPI Study)CompletedNCT02805049Phase 4
• Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)Status unknownNCT02803346
• Study of Progression of Community Acquired Pneumonia in the HospitalCompletedNCT02782013
• Observational Study on Intubation in Septic ShockCompletedNCT02780466
• Midodrine During Recovery From Septic ShockWithdrawnNCT02771158Phase 4
• Hydrocortisone 50 mg Every 6 Hours Compared to Hydrocortisone 300 mg Per Day in Treatment of Septic Shock.CompletedNCT02768740Phase 4
• Norepinephrine Exerts an Inotropic Effect at the Early Phase of Human Septic ShockCompletedNCT02750683
• Circulating Free Hemoglobin and Microcirculation After Administration of Paracetamol in Febrile Septic PatientCompletedNCT02750163
• Fluids in Sepsis and Septic ShockCompletedNCT02748382Phase 2/3
• (1,3)-β-D-glucan Based Diagnosis of Invasive Candida Infection in SepsisCompletedNCT02734550Not applicable
• Optimized Caloric-proteic Nutrition in Septic and Septic Shock PatientsTerminatedNCT02731144Phase 4
• Piperacillin/Tazobactam in Critically Ill Patients With Severe Sepsis and Septic ShockCompletedNCT02730624Phase 4
• Effect of Albumin Administration on Vasopressor Duration in Resolving Septic ShockTerminatedNCT02716597Phase 1
• Impact of Early Goal-Directed Therapy to Perfusion and Metabolism of BrainStatus unknownNCT02706379Not applicable
• Neutrophil FFA2/GPR43 Receptor Expression in Patients With the Diagnosis of SepsisWithdrawnNCT02699905
• Characterization of Hemostatic Disordres in Septic Shock: Searching for Biological MarkersStatus unknownNCT02692053Not applicable
• Study the Impact of Statins in Septic ShockCompletedNCT02681653Not applicable
• Fluid Responsiveness in Septic Shock Evaluated by Caval Ultrasound Doppler ExaminationStatus unknownNCT02676427
• L-carnitine as an Adjunct Treatment for Septic Shock Patients With Acute Kidney InjuryTerminatedNCT02664753Phase 3
• COrporeal Compression at the ONset of Severe Sepsis and Septic ShockCompletedNCT02656654Not applicable
• Effects on Microcirculation of IgGAM in Severe Septic/Septic Shock Patients.CompletedNCT02655133Phase 2
• Ulinastatin Treatment in Adult Patients With Sepsis and Septic Shock in ChinaCompletedNCT02647554Phase 4
• Effects of Levosimendan, Milrinone and Norepinephrine on Left and Right Ventricular Function in Septic ShockStatus unknownNCT02640846Phase 4
• REAnimation Low Immune Status MarkersCompletedNCT02638779Not applicable
• Hemodynamic Effects of Dexmedetomidine in Septic ShockCompletedNCT02638545Phase 3
• Study of Platelet Activation in Septic Shock PatientsCompletedNCT02635854Not applicable
• Early Goal Directed Sedation on Microcirculation in Septic ShockStatus unknownNCT02612363Phase 4
• Dex on Microcirculation in SS-A Double-blinded StudyStatus unknownNCT02612181Phase 4
• Effect of a Continuous Infusion of Esmolol on Stroke Volume in Patients With Hyperdynamic Vasoplegic Septic ShockWithdrawnNCT02609152Phase 3
• Comparing Cytokines, Toxins Adsorbing oXiris Filter to ST150 Filter During CRRT in Patients With Septic ShockCompletedNCT02600312Not applicable
• Targeted Tissue Perfusion Versus Macrocirculatory-guided Standard Care in Patients With Septic ShockCompletedNCT02579525Not applicable
• The Effect of Lactate Clearance Oriented Haemodynamic Therapy on the Outcome of Patients With Septic ShockCompletedNCT02566460Not applicable
• Volemic Resuscitation in Sepsis and Septic ShockStatus unknownNCT02565251Not applicable
• TOADS Study: TO Assess Death From Septic Shock.Status unknownNCT02547467
• Microcirculation After MAP Increase in Septic Shock Patients With Previous HypertensionCompletedNCT02519699Phase 4
• The Pharmacokinetics/Pharmacodynamics of High-dose Daptomycin in Patients With Septic ShockStatus unknownNCT02508350Not applicable
• Piperacillin Pharmacokinetics in ICU PatientsStatus unknownNCT02478073
• Samu Save Sepsis: Early Goal Directed Therapy in Pre Hospital Care of Patients With Severe Sepsis and/or Septic ShockCompletedNCT02473263Phase 3
• To Assess the Efficacy of Early Introduction of a Combination of Low Dose Vasopressin Analogue in Addition to Noradrenaline as a Vasopressor in Patients of Cirrhosis With Septic ShockCompletedNCT02468063Not applicable
• Interest of Plasma microRNAsCompletedNCT02464371
• NOrepinephrine and VasoprEssin Versus Norepinephrine aLone in Critically Ill Patients With Septic ShockWithdrawnNCT02454348Phase 4
• The Effects of Blood Pressure on Renal Function and Oxygenation in Septic ShockCompletedNCT02453425Not applicable
• Anisodamine Critically Ill SeptIc ShockCompletedNCT02442440Phase 1/2
• Microcirculatory Oxygen Uptake in SepsisCompletedNCT02430142
• Clinical Practice Guidelines and Impact of Audit and Feedback in the Emergency DepartmentCompletedNCT02427048Not applicable
• Sepsis Assessment in Belgian Emergency RoomsTerminatedNCT02424721
• Cellular Immunotherapy for Septic Shock: A Phase I TrialCompletedNCT02421484Phase 1
• Adrenomedullin and Outcome in Severe Sepsis and Septic ShockCompletedNCT02393781
• Membrane Shedding During Severe Sepsis and Septic Shock: Pathophysiological and Clinical RelevanceStatus unknownNCT02391792

← Shock, Septic overview